Skandinaviska Enskilda Banken AB (publ) - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2021$414,000
-62.0%
29,577
-51.3%
0.00%
-66.7%
Q3 2021$1,090,000
+4.7%
60,7590.0%0.01%0.0%
Q2 2021$1,041,000
+231.5%
60,759
+252.3%
0.01%
+100.0%
Q3 2019$314,000
-72.3%
17,247
-45.8%
0.00%
-70.0%
Q2 2019$1,134,000
+19.1%
31,847
+12.5%
0.01%
+11.1%
Q1 2019$952,000
-10.4%
28,297
-12.5%
0.01%
-10.0%
Q4 2018$1,063,000
-20.1%
32,343
+48.2%
0.01%0.0%
Q3 2018$1,330,000
+13.3%
21,820
-9.2%
0.01%0.0%
Q2 2018$1,174,000
-23.8%
24,020
+65.7%
0.01%
-33.3%
Q1 2018$1,541,00014,5000.02%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 432,952$1,385,0000.91%
GREAT POINT PARTNERS LLC 447,820$1,433,0000.34%
Birchview Capital, LP 128,000$410,0000.29%
Edgestream Partners, L.P. 1,047,636$3,352,0000.26%
Rhenman & Partners Asset Management AB 550,000$2,068,0000.22%
CM Management, LLC 50,000$160,0000.18%
TANG CAPITAL MANAGEMENT LLC 430,037$1,376,0000.17%
PDT Partners, LLC 307,953$985,0000.15%
Virtus ETF Advisers LLC 72,018$230,0000.09%
ALGERT GLOBAL LLC 476,412$1,525,0000.09%
View complete list of NEKTAR THERAPEUTICS shareholders